Medium materiality5/10
RxSight price target lowered to $7 from $8 at Stifel
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target lowered to $7; price $6.26; Stifel.
- RXST PT $7; price $6.26.
Key facts
- 01
Target: $7
- 02
Posted price: $6.26
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.